Precision Neuroscience
A new interface between the human brain and technology
NEUROTECH / MEDICAL TECHNOLOGY
Precision Neuroscience develops brain-computer interface technology designed to help people with neurological conditions interact with digital devices. Its Layer 7 cortical interface is being developed alongside clinical, regulatory and manufacturing capabilities.
PRIVATE MARKET ACCESS | FROM USD 100,000
Private company allocations are often concentrated among venture capital funds and larger institutional investors. This structured route offers eligible investors the opportunity to consider exposure from USD 100,000, subject to availability and suitability. Direct private-market transactions may require larger blocks, although lower-minimum alternatives also exist.
OPPORTUNITY ATTRACTION
Institutional conviction
Oversubscribed Series D co-led by Pershing Square, the Ackman Oxman Institute and a leading life-sciences fund; ARK Invest and Mubadala Capital also participated.Clinical momentum
More than 100 patient procedures across 18 medical institutions, according to the company.Commercial foundations
FDA-cleared temporary-use Layer 7 cortical interface, a Medtronic partnership and an owned manufacturing facility in Texas.
Minimum indicative subscription: USD 100,000. Indicative investor entry price shown is inclusive of the proposed 10% upfront loading. No carried interest is proposed. Subject to availability, verified allocation terms and applicable approvals.
INVESTMENT STRUCTURE & KEY RISKS \\ Exposure is through a dedicated investment structure and an unsecured, subordinated Participation Note, not direct ownership of company shares. Capital is at risk, the investment may be illiquid and the issuer or underlying company may fail. No investor protection or exit is guaranteed. Sources: Precision Neuroscience release, 24 Sep 2026; Sacra valuation profile (2026). | Prepared 13 October 2026. For discussion only; not an offer or recommendation.
NEXT GROWTH CATALYST
Expansion of clinical programmes, further regulatory progress and development of commercial applications.
IPO OUTLOOK
No confirmed IPO timetable or offering price. A listing, its timing and any valuation uplift are uncertain.
*IMPORTANT NOTICE
The information contained in this material is provided for general informational purposes only and does not constitute financial, legal, tax, regulatory or accounting advice. Strategin Consulting Group and its affiliates do not provide legal or tax advisory services unless expressly engaged to do so under a separate written mandate. Readers should seek independent professional advice before entering into any transaction, restructuring exercise or investment decision. Any references to structures, jurisdictions, asset classes, operational frameworks or strategic considerations are illustrative in nature and may not be suitable for all circumstances. The appropriateness of any strategy depends on a range of factors including regulatory environment, liquidity requirements, commercial objectives, risk tolerance and tax position.
RISK CONSIDERATIONS
All investments and commercial activities carry risk. Market conditions, geopolitical developments, regulatory changes, currency movements and operational disruptions may materially affect outcomes. Past performance is not indicative of future results, and no representation is made that any strategy or structure discussed will achieve comparable outcomes in future environments. Diversification, governance frameworks and strategic planning may reduce certain exposures but cannot eliminate risk entirely or guarantee profitability, continuity or capital preservation. Forward-looking statements reflect current assumptions and judgment at the time of publication and should not be interpreted as assurances of future performance. Any projections, scenario analyses or hypothetical illustrations are provided solely for reference purposes. Actual outcomes may differ materially depending on timing, implementation, market conditions and jurisdictional considerations.
NON-RELIANCE
While Strategin Consulting Group believes the information contained herein to be derived from sources considered reliable, no representation or warranty, express or implied, is made regarding its accuracy, completeness or ongoing validity. Information may change without notice and Strategin Consulting Group assumes no obligation to update or revise any content following publication. Nothing in this material should be construed as an offer, solicitation, recommendation or invitation to engage in any transaction, investment or advisory relationship. Any engagement between Strategin Consulting Group and a client is governed exclusively by the terms of a formal written agreement. This material may contain commentary, opinions or strategic observations formed under prevailing market and geopolitical conditions. Such views are inherently subject to change and may differ from opinions expressed by other parties, institutions or market participants.
Readers remain solely responsible for conducting their own independent assessment and obtaining appropriate professional advice prior to making financial, operational or strategic decisions.
© 2025 Strategin Consulting Group Limited \\ IBC No. 247501 \\ Office F2-2A, Oceanic House, Providence Estate, Mahé, Seychelles \\ +248 4373 733 \\ info@thinkstrategin.com
Strategin Consulting Group Limited (SCG) is an independent strategic consulting firm. The International Business Company (IBC) is not a licensed financial services provider and does not undertake investment management, financial advisory, fiduciary, custodial or other regulated financial activities. Where appropriate, Strategin Consulting Group facilitates introductions to independent third-party firms that are duly authorised and regulated within their respective jurisdictions. Any regulated services are provided exclusively by those external firms in accordance with their own regulatory obligations, engagement terms and supervisory frameworks. The Company may receive referral fees in connection with certain introductions. Such arrangements do not affect the independence of its strategic advisory perspective or the selection of appropriate specialist providers. All information presented on this website and in communication issued by SCG is provided solely for general informational and educational purposes, is non-solicitational in nature and does not constitute an offer, invitation, recommendation or solicitation to engage in any investment, financial, legal, tax or other regulated activity. It does not constitute financial, investment, legal, tax or strategic advice and should not be relied upon as such. Any engagement with Strategin Consulting Group is subject to formal agreement and applicable terms & conditions. Each matter is assessed individually in light of the specific circumstances of the relevant client or venture.